SCHEMBL1245320

SCHEMBL1245320

CCOC(=O)N(c1ccccc1Cl)c1c(-c2ccc(-c3cccc(C(=O)O)c3)cc2)noc1C

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 10/20 0.45
LIFR P42702 1/20 0.45
HSD17B13 Q7Z5P4 1/20 0.42
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
PTGS2 P35354 1/20 0.40
TSHR P16473 2/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1247124 0.96 NR1H4 (0.43) NR1H4LIFRHSD17B13MAPTALDH1A1
SCHEMBL1247564 0.92 MAPT (0.42) NR1H4MAPTALDH1A1POLBHPGD
SCHEMBL1246239 0.90 MAPT (0.39) NR1H4LIFRMAPTALDH1A1POLB
SCHEMBL1246422 0.89 KMO (0.41) NR1H4LIFRMAPTALDH1A1POLB
SCHEMBL1246307 0.88 NR1H4 (0.44) NR1H4MAPTPTGS2TSHRGPBAR1
SCHEMBL1245111 0.88 NR1H4 (0.50) NR1H4LIFRHPGDLMNATDP1
SCHEMBL1246467 0.87 NR1H4 (0.43) NR1H4PTGS2GPBAR1SCN9A
SCHEMBL1246421 0.86 SCN9A (0.39) MAPTALDH1A1POLBHPGDLMNA
SCHEMBL2336147 0.86 NR1H4 (0.42) NR1H4LIFRHSD17B13LMNAGAA
SCHEMBL1247222 0.85 ALDH1A1 (0.36) MAPTALDH1A1POLBHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462128-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
WO-2011017350-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed